|
?:authorAffiliation
|
-
[\'Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. n.han@milner.cam.ac.uk t.kouzarides@gurdon.cam.ac.uk.\', \'Milner Therapeutics Institute, University of Cambridge, Cambridge, UK.\', \'Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, Gießen 35392, Germany.\', \'Centre for Therapeutics Discovery, LifeArc, Stevenage, UK.\', \'Department of Surgery, University of Cambridge, Cambridge, UK.\', \'Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.\', \'Department of Chemistry, University of Cambridge, Cambridge, UK.\', \'Data and Computational Sciences, GSK, London, UK.\', \'Department of Medicine, University of Cambridge, Cambridge, UK.\', \'The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}